Literature DB >> 24308742

Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay.

Udo Meinhardt1, Urs Eiholzer, Lisa Seitz, Mette Bøgelund, Anne-Marie Kappelgaard.   

Abstract

Sustained treatment adherence, usually over long periods of time, is critical to the success of growth hormone (GH) therapy. However, adherence rates are often poor which may result in suboptimal clinical outcomes. The type of device used by patients to administer their GH can influence adherence. Offering patients a choice of device maximizes the chance of adherence to treatment. Multiple factors will influence a patient's choice of device, depending on individual priorities. This study evaluated the most preferred features of GH injection devices by parents using a web-based questionnaire and as assessed by their willingness to pay for specific device features. The results show that parents are willing to pay for device features facilitating ease of use.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24308742     DOI: 10.1586/17434440.2014.856754

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

Review 1.  Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care.

Authors:  Carlo L Acerini; David Segal; Sherwin Criseno; Kei Takasawa; Navid Nedjatian; Sebastian Röhrich; Mohamad Maghnie
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-22       Impact factor: 5.555

2.  Clinicians' Feedback on Patient/Carer Experience After Switching of Growth Hormone Treatment in Pediatric Patients During COVID-19.

Authors:  Joanne Blair; Kelly Warth; Yashasvi Suvarna; Marco Cappa
Journal:  Patient Prefer Adherence       Date:  2021-09-21       Impact factor: 2.711

3.  Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.

Authors:  Jens Sandahl Christiansen; Philippe F Backeljauw; Martin Bidlingmaier; Beverly M K Biller; Margaret C S Boguszewski; Felipe F Casanueva; Philippe Chanson; Pierre Chatelain; Catherine S Choong; David R Clemmons; Laurie E Cohen; Pinchas Cohen; Jan Frystyk; Adda Grimberg; Yukihiro Hasegawa; Morey W Haymond; Ken Ho; Andrew R Hoffman; Jeff M P Holly; Reiko Horikawa; Charlotte Höybye; Jens Otto L Jorgensen; Gudmundur Johannsson; Anders Juul; Laurence Katznelson; John J Kopchick; K O Lee; Kuk-Wha Lee; Xiaoping Luo; Shlomo Melmed; Bradley S Miller; Madhusmita Misra; Vera Popovic; Ron G Rosenfeld; Judith Ross; Richard J Ross; Paul Saenger; Christian J Strasburger; Michael O Thorner; Haim Werner; Kevin Yuen
Journal:  Eur J Endocrinol       Date:  2016-03-23       Impact factor: 6.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.